Protagonist Therapeutics Inc. (PTGX)
Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XMEX $
146. 49
-1.26
-0.8528%
After Hours
$
+5.54 +3.7818% 152. 03
9.5B Market Cap
- P/E Ratio
- Div Yield
534,120 Volume
0.75 Eps
$ 147.75
Previous Close 
Want to track PTGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Protagonist Therapeutics Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| GM Geoff Meacham Citigroup | 668.57 | $97,730.87 | $103,694.48 | $5,963.61 | 6.1% |
| RL Richard Law Goldman Sachs | 1,445.61 | $216,841.38 | $224,214.01 | $7,372.63 | 3.4% |
